Search Results - "Sherrer, Yvonne S"

Successful Treatment of Dry Mouth and Dry Eye Symptoms in Sjögrenʼs Syndrome Patients With Oral Pilocarpine: A Randomized, Placebo-Controlled, Dose-Adjustment Study by Papas, Athena S, Sherrer, Yvonne S, Charney, Michael, Golden, Harvey E, Medsger, Thomas A, Walsh, Bridget T, Trivedi, Madhu, Goldlust, Barry, Gallagher, Susan C

“…BACKGROUND:Sjögren’s syndrome is characterized by the presence of xerostomia and/or xerophthalmia. Pilocarpine, a muscarinic cholinergic agonist, has been…”
Get full text

Effects of Prasterone on Bone Mineral Density in Women with Active Systemic Lupus Erythematosus Receiving Chronic Glucocorticoid Therapy by SANCHEZ-GUERRERO, Jorge, FRAGOSO-LOYO, Hilda E, DEODHAR, Atul A, BLANTON, Ellen, MANZI, Susan, KAVANAUGH, Arthur, LISSE, Jeffrey R, RAMSEY-GOLDMAN, Rosalind, MCKAY, James D, KIVITZ, Alan J, MEASE, Philip J, WINKLER, Anne E, NEUWELT, C. Michael, KAHL, Leslie E, LEE, Albert H, FURIE, Richard A, VIBEKE STRAND, C, LOU, Lillian, AHMED, Mumtaz, QUARLES, Betty, SCHWARTZ, Kenneth E, WALLACE, Daniel J, GINZLER, Ellen M, SHERRER, Yvonne R. S, MCILWAIN, Harris H, FREEMAN, Pamela G, ARANOW, Cynthia, PETRI, Michelle A

“…Objective To assess prevention of bone mineral density (BMD) loss and durability of the response during treatment with prasterone in women with systemic lupus…”
Get full text

The development of disability in rheumatoid arthritis by Sherrer, Y S, Bloch, D A, Mitchell, D M, Young, D Y, Fries, J F

“…Six hundred eighty-one consecutive patients with rheumatoid arthritis were followed for an average of 11.9 years to identify initial factors that predicted…”
Get more information